Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Anantpadma

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The EMBO Journal|July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infectionJyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
Cell Reports|April 14, 2015
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA InteractionsDaisy W Leung, Dominika Borek, Priya Luthra, et al.
Journal of Medicinal Chemistry|December 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg VirusesMalaika D Argade, Jazmin Galván Achi, Ryan Bott, et al.
Cell|December 15, 2018
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus ReplicationJyoti Batra, Judd F Hultquist, Dandan Liu, et al.
Journal of Molecular Biology|February 6, 2014
In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activityCraig S Brown, Michael S Lee, Daisy W Leung, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivoJ J Patten, Patrick T Keiser, Deisy Gysi, et al.
Iscience|August 22, 2022
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationJ J Patten, Patrick T Keiser, Deisy Morselli-Gysi, et al.
The Journal of Infectious Diseases|June 4, 2018
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman PrimatesKristen E Pascal, Drew Dudgeon, John C Trefry, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The EMBO Journal|July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infectionJyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
Cell Reports|April 14, 2015
An Intrinsically Disordered Peptide from Ebola Virus VP35 Controls Viral RNA Synthesis by Modulating Nucleoprotein-RNA InteractionsDaisy W Leung, Dominika Borek, Priya Luthra, et al.
Journal of Medicinal Chemistry|December 16, 2024
Guardians at the Gate: Optimization of Small Molecule Entry Inhibitors of Ebola and Marburg VirusesMalaika D Argade, Jazmin Galván Achi, Ryan Bott, et al.
Cell|December 15, 2018
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus ReplicationJyoti Batra, Judd F Hultquist, Dandan Liu, et al.
Journal of Molecular Biology|February 6, 2014
In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activityCraig S Brown, Michael S Lee, Daisy W Leung, et al.
Journal of Medicinal Chemistry|January 6, 2026
Discovery and Optimization of First-in-Class Furopyrimidine-Based Inhibitors of HenipavirusesIrina N Gaisina, Malaika D Argade, Ryan Bott, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2021
Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivoJ J Patten, Patrick T Keiser, Deisy Gysi, et al.
Iscience|August 22, 2022
Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritizationJ J Patten, Patrick T Keiser, Deisy Morselli-Gysi, et al.
The Journal of Infectious Diseases|June 4, 2018
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman PrimatesKristen E Pascal, Drew Dudgeon, John C Trefry, et al.
Pageof 4